A detailed history of Lindbrook Capital, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 154 shares of NUVB stock, worth $417. This represents 0.0% of its overall portfolio holdings.

Number of Shares
154
Holding current value
$417
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$2.3 - $3.83 $354 - $589
154 New
154 $0
Q2 2023

Jul 28, 2023

BUY
$1.56 - $1.84 $1,212 - $1,429
777 Added 473.78%
941 $1,000
Q1 2023

Apr 26, 2023

SELL
$1.6 - $2.48 $4,352 - $6,745
-2,720 Reduced 94.31%
164 $0
Q4 2022

Jan 24, 2023

BUY
$1.68 - $2.5 $3,449 - $5,132
2,053 Added 247.05%
2,884 $0
Q3 2022

Nov 10, 2022

BUY
$0.29 - $4.04 $240 - $3,357
831 New
831 $2,000

Others Institutions Holding NUVB

About Nuvation Bio Inc.


  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $589M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.